Back
Innovent Biologics Vs. Apogee Enterprises Industry Stock Comparison
Sell
21
IVBXF
Innovent Biologics
Last Price:
$4.00
Seasonality Move:
-4.36%
Sell
48
APOG
Apogee Enterprises
Last Price:
$55.73
Seasonality Move:
4.54%
Sell
21
Innovent Biologics (IVBXF)
is a Sell
Is Innovent Biologics a Buy, Sell or Hold?
-
The current Innovent Biologics [IVBXF] share price is $4.00. The Score for IVBXF is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
-
IVBXF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Apogee Enterprises (APOG)
is a Sell
Is Apogee Enterprises a Buy, Sell or Hold?
-
The current Apogee Enterprises [APOG] share price is $56.73. The Score for APOG is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
APOG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IVBXF Stock Price Chart
What is Innovent Biologics's stock price today?
-
The Innovent Biologics share price today is $4.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IVBXF is experiencing slight buying pressure.
APOG Stock Price Chart
What is Apogee Enterprises's stock price today?
-
The Apogee Enterprises share price today is $56.73Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APOG is experiencing selling pressure, which indicates risk of future bearish movement.
IVBXF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 24.9 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.24 - 4.8) | Sell |
| Bollinger Bands (100): | (4.51 - 5.73) | Sell |
APOG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.77 | Sell |
| Relative Strength Index (14 RSI): | 32.12 | Sell |
| Chaikin Money Flow: | -275477 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.39 - 74.47) | Sell |
| Bollinger Bands (100): | (63.92 - 81.94) | Sell |
IVBXF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.2 | Sell |
| 20-day SMA: | 4.45 | Sell |
| 50-day SMA: | 4.64 | Sell |
| 200-day SMA: | 5.03 | Sell |
| 8-day EMA: | 4.16 | Sell |
| 20-day EMA: | 4.39 | Sell |
| 50-day EMA: | 4.67 | Sell |
| 200-day EMA: | 4.98 | Sell |
APOG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.54 | Buy |
| 20-day SMA: | 63.17 | Sell |
| 50-day SMA: | 74.25 | Sell |
| 200-day SMA: | 67.82 | Sell |
| 8-day EMA: | 56.83 | Sell |
| 20-day EMA: | 62.06 | Sell |
| 50-day EMA: | 69.05 | Sell |
| 200-day EMA: | 67.43 | Sell |
Innovent Biologics Earnings Growth & IVBXF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Apogee Enterprises Earnings Growth & APOG Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.29 per share, and a decrease next year of $0.66 per share.
Innovent Biologics Technical Analysis
| Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apogee Enterprises Technical Analysis
| Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||